Inhibition of type IIA secretory phopholipase A2 reduces cell-death of cardiomyocytes in acute myocardial infarction in rats

Vermond, R.A.; Van Dijk, A.; Krijnen, P.A.J.; Spreeuwenberg, M.D.; Visser, F.C.; Van Milligen, F.J.; Niessen, H.W.M.
June 2008
European Journal of Heart Failure. Supplements;Jun2008, Vol. 7 Issue 1, p139
Academic Journal
An abstract of the article "Inhibition of type IIA secretory phopholipase A2 reduces cell-death of cardiomyocytes in acute myocardial infarction in rats," by R. A. Vermond and colleagues is presented.


Related Articles

  • Structural and Functional Characterization of a γ-Type Phospholipase A2 Inhibitor from Bothrops jararacussu Snake Plasma. Oliveira, Clayton Z.; Santos-Filho, Norival A.; Menaldo, Danilo L.; Boldrini-França, Johara; Giglio, José R.; Calderon, Leonardo A.; Stábeli, Rodrigo G.; Rodrigues, Fabio H. S.; Tasic, Ljubica; da Silva, Saulo L.; Soares, Andreimar M. // Current Topics in Medicinal Chemistry;Oct2011, Vol. 11 Issue 20, p2509 

    Phospholipases A2 (PLA2s) from snake venoms comprise a group of 14-18 kDa proteins, responsible for several toxic effects induced by the whole venom. Considering this, studies aiming at the search for natural inhibitors of these proteins are very important. The present work had as objectives the...

  • Pharmacological Modulation of Diacylglycerol-Sensitive TRPC3/6/7 Channels. Harteneck, Christian; Gollasch, Maik // Current Pharmaceutical Biotechnology;Jan2011, Vol. 12 Issue 1, p35 

    No abstract available.

  • Role of Phospholipase A2 in Retrograde Transport of Ricin. Klokk, Tove Irene; Lingelem, Anne Berit Dyve; Myrann, Anne-Grethe; Sandvig, Kirsten // Toxins;Sep2011, Vol. 3 Issue 9, p1203 

    Ricin is a protein toxin classified as a bioterror agent, for which there are no known treatment options available after intoxication. It is composed of an enzymatically active A-chain connected by a disulfide bond to a cell binding B-chain. After internalization by endocytosis, ricin is...

  • Varespladib linked to greater incidence of MI in ACS patients. Ellis, Brian; Kalvaitis, Katie; Swain, Erik // Cardiology Today;Feb2014, Vol. 17 Issue 2, p17 

    The article discusses a study by Stephen J. Nicholls and published in a 2014 issue of the "Journal of the American Medical Association," which found that Varespladib, a novel secretory phospholipase A2 inhibitor is associated to greater incidence of myocardial infarction in acute coronary...

  • Synthesis of Azetidin-2-One Derivatives as Inhibitor of Secretory Phospholipase A2 with Anti-Inflammatory Activity. Yerigeri, Mayur C.; Murari, Satish K.; Mohammed, Salahuddin; Math, Shanta Kumar Sugur; Thimmaiah, Kuntebommanahalli N.; Vishwanath, Bannikuppe Sannanaik // Letters in Drug Design & Discovery;Jun2005, Vol. 2 Issue 4, p307 

    The title compounds have been synthesized and tested for structure activity relationship for Phospholipase A2 (PLA2) [E.C.] enzyme inhibition. The in vitro PLA2 enzyme inhibitory activity of azetidin-2-one derivatives and in vivo anti-inflammatory activity studies using mice are...

  • cPLA2 Is Protective Against COX Inhibitor–Induced Intestinal Damage. Montrose, David C.; Kadaveru, Krishna; Ilsley, Jillian N. M.; Root, Sierra H.; Rajan, Thiruchanduri V.; Ramesh, Manish; Nichols, Frank C.; Liang, Bruce T.; Sonin, Dmitry; Hand, Arthur R.; Zarini, Simona; Murphy, Robert C.; Belinsky, Glenn S.; Nakanishi, Masako; Rosenberg, Daniel W. // Toxicological Sciences;Sep2010, Vol. 117 Issue 1, p122 

    Cytosolic phospholipase A2 (cPLA2) is the rate-limiting enzyme responsible for the generation of prostaglandins (PGs), which are bioactive lipids that play critical roles in maintaining gastrointestinal (GI) homeostasis. There has been a long-standing association between administration of...

  • Neutralization of Local Toxicity Induced by Vipera russelli Phospholipase A2 by Lipophilic Derivative of Ascorbic Acid. Mohamed, Riyaz; Shivaprasad, Holenarasipura V.; Jameel, Noor M.; Shekar, Mysore A.; Vishwanath, Bannikuppe S. // Current Topics in Medicinal Chemistry;Oct2011, Vol. 11 Issue 20, p2531 

    L-ascorbic acid upon condensation with palmitic acid in the presence of sulphuric acid results in L-ascorbic acid-6-palmitate (AP). The effect of L-ascorbic acid derivative, AP on the pharmacological activities of purified basic multi-toxic PLA2 enzyme, VRV-PL-VIIIa from Vipera russelli snake...

  • Therapeutic Potential of Peptides with Neutralizing Ability Towards the Venom and Toxin (CaTx-I) of Crotalus adamanteus. Samy, Ramar Perumal; Thwin, Maung Maung; Stiles, Bradley G.; Bow, Ho; Chow, Vincent T. K.; Gopalakrishnakone, Ponnampalam // Current Topics in Medicinal Chemistry;Oct2011, Vol. 11 Issue 20, p2540 

    The CaTx-I (PLA2) toxin of Crotalus adamanteus venom is responsible for most of the symptoms observed during envenomation. Synthetic peptides were designed and screened for venom (0.8 µg/ml) and CaTx-I (0.1 µM) inhibition at varying doses of the peptide (10000- 0.0001 µM) using a Cayman...

  • Group IIA Secretory PLA2 Inhibition by Ursolic Acid: A Potent Anti-Inflammatory Molecule. Nataraj, A.; Gowda, C. D. Raghavendra; Rajesh, R.; Vishwanath, B. S. // Current Topics in Medicinal Chemistry;Apr2007, Vol. 7 Issue 8, p801 

    Ursolic acid (3β-hydroxy-urs-12-en-28-oic acid) isolated from many medicinal plants has diverse pharmacologically important properties, including strong anti-inflammatory activity. However its interaction with proinflammatory PLA2 is not known. Ursolic acid inhibited secretory PLA2 (sPLA2)...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics